(12 years, 10 months ago)
Commons ChamberMay I appeal to Members not to pass that rather unglamorous specimen around the Chamber? The hon. Member for Mid Norfolk (George Freeman), to whom I have been generous, should secrete his graphene away, and behave with the tact and discretion for which he was previously renowned.
I beg to disagree, Mr Speaker. Graphene is very glamorous, and it is a fantastic discovery, made in Manchester. The Minister will be aware from his appearances before the Science and Technology Committee that there is a huge imbalance between the public investment in science in the golden triangle between Oxford, Cambridge and London, and investment in the rest of the country. Is this not a great opportunity to invest the vast bulk of that £50 million in Manchester, where the two Nobel laureates discovered graphene?
The hon. Gentleman makes a clear case. Of course, the issue is now being investigated by the EPSRC and the TSB, but we recognise the crucial role that Manchester played in the discovery, and I am sure that its role will continue.
(13 years ago)
Commons Chamber9. What steps he plans to take to protect stem cell research in the UK following the decision of the European Court of Justice to prohibit the patenting of inventions based on human stem cells; and if he will make a statement.
We are—[Interruption.] We are carefully considering the impact of the ruling—[Interruption.]
I will do my best, Mr Speaker.
As I was saying, we are carefully considering the impact of the ruling on current UK patent practice. The Technology Strategy Board currently funds 15 studies involving human stem cells, two of which use human embryonic stem cells. The TSB and the research councils will continue to support and fund research on stem cells from all sources, including embryonic.
That was an interesting reply, because leading scientists in the field have called the decision everything from “devastating” to “appalling”. They believe this work will move to South Korea and Canada, and that potential cures for people suffering from degenerative diseases will be developed later, if they are developed at all. I simply do not understand the Minister’s answer, and I would like more details on how he is going to stop this work going abroad.
I agree with the hon. Gentleman that this research is very important in tackling fundamental human illnesses such as Parkinson’s, and that is why we will continue to support it. We are assessing the implications of the ECJ ruling. It is important that stem cells can be derived in a variety of ways, and embryonic stem cells are only one source of stem cells. That is why we need more time to assess the implications of this judgment.
(13 years, 6 months ago)
Commons ChamberI am afraid that I do not recognise those specific figures. We are talking about a system whose powerful logic is simple—no student pays up front, a point that my hon. Friend the Member for Beverley and Holderness correctly made.
I am responding to the point made by the hon. Member for Stoke-on-Trent Central (Tristram Hunt); it is an important stage in the argument. The money must be accompanied by reform that puts teaching up front and enables students, for the first time, to choose the course and university that they believe will best meet their needs. That is why the Secretary of State and I are absolutely committed to ensuring that it is easier for universities to escape from the shackles of the detailed quotas and restrictions set, university by university, in the system that we inherited from the previous Government. One of our highest priorities is to ensure that our reforms also improve the quality of the student experience. That will be at the heart of our White Paper.
Will the Minister explain how the quality of education will improve? Due to his miscalculations about the number of universities charging £9,000 and the structure of the students who will be going, there will be a huge deficit. That will lead to cuts in universities or in the number of students going to universities.
Let me deal briefly with that point. A fortnight ago, the Labour party was claiming that there was a £1 billion shortfall; last week, apparently, the shortfall was £450 million. We simply do not recognise those figures. We will see in autumn next year exactly what students are paying and how much they choose to borrow; they do not necessarily even need to borrow the full amount of fees that they face. That will be a decision for them. At that point, we will assess the financial situation that we face, but we see no reason to amend the broad estimate that we put before the House last autumn.